(ABEV) Ambev - Ratings and Ratios

Exchange: NYSE • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: US02319V1035

ABEV: Beer, Soft Drinks, Water, Energy Drinks, Juices

Ambev S.A., a subsidiary of Interbrew International B.V., operates as a leading beverage company, specializing in the production, distribution, and sale of a diverse portfolio of alcoholic and non-alcoholic beverages. Its product range includes beer, carbonated soft drinks, bottled water, isotonic beverages, energy drinks, and ready-to-drink teas. The company markets its products under a wide array of brands, including Skol, Brahma, Antarctica, Budweiser, Stella Artois, Corona, Guaraná Antarctica, Pepsi-Cola, and Gatorade, among others. Ambevs distribution network spans multiple regions, including Brazil, Central America, the Caribbean, Latin America South, and Canada, utilizing both third-party distributors and a direct distribution system. Founded in 1885 and headquartered in São Paulo, Brazil, the company has established itself as a major player in the global beverage industry, with a strong focus on market penetration and brand diversification.

Over the next three months, Ambevs stock is expected to show moderate volatility, with potential upside driven by its stable financials and market position. Based on , the stock is currently trading above its SMA20 and SMA50, indicating short-term bullish momentum, though the SMA200 suggests a longer-term sideways trend. The ATR of 0.07 signals moderate price fluctuations. From a perspective, Ambevs P/E ratio of 15.00 and forward P/E of 13.91 indicate reasonable valuations, while its P/S ratio of 0.42 reflects efficient revenue generation. The companys RoE of 14.64% highlights strong profitability. Considering these factors, the stock is likely to trade within a narrow range, with potential resistance near $2.50 and support around $2.20, driven by stable earnings and market conditions.

Ticker Symbol: ABEV Exchange: NYSE Type: common stock Country Origin: Brazil GICS Sub Industry: Brewers Average Volume 20d: 23634256 Last Price: 2.40 SMA 20: 2.31 SMA 50: 2.15 SMA 200: 2.08 ATR: 0.07 Market Cap: 37553.28M USD P/E: 15.00 P/E Forward: 13.91 P/B: 2.24 P/S: 0.42 RoE: 14.64

Additional Sources for ABEV Stock

ABEV Stock Overview

Market Cap in USD 37,553m
Sector Consumer Defensive
Industry Beverages - Brewers
GiC Sub-Industry Brewers
IPO / Inception 1997-03-05

ABEV Stock Ratings

Growth Rating 14.3
Fundamental 83.0
Dividend Rating 61.1
Rel. Strength -2.13
Analysts 3.91/5
Fair Price Momentum 2.43 USD
Fair Price DCF 29.27 USD

ABEV Dividends

Dividend Yield 12m 5.68%
Yield on Cost 5y 7.72%
Annual Growth 5y 5.66%
Payout Consistency 81.2%

ABEV Growth Ratios

Growth Correlation 3m 91%
Growth Correlation 12m 10.4%
Growth Correlation 5y -4.5%
CAGR 5y 7.98%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m -0.15
Alpha 6.83
Beta -0.099
Volatility 34.00%
Current Volume 32568k
Average Volume 20d 41063k
What is the price of ABEV stocks?
As of May 05, 2025, the stock is trading at USD 2.49 with a total of 32,567,989 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +7.79%, over three months by +36.61% and over the past year by +8.74%.
Is Ambev a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Ambev (NYSE:ABEV) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.01 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABEV as of May 2025 is 2.43. This means that ABEV is currently overvalued and has a potential downside of -2.41%.
Is ABEV a buy, sell or hold?
Ambev has received a consensus analysts rating of 3.91. Therefor, it is recommend to buy ABEV.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 4
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ABEV stock price target?
According to ValueRays Forecast Model, ABEV Ambev will be worth about 2.6 in May 2026. The stock is currently trading at 2.49. This means that the stock has a potential upside of +5.62%.
Issuer Forecast Upside
Wallstreet Target Price 2.9 15.7%
Analysts Target Price 3.1 23.7%
ValueRay Target Price 2.6 5.6%